2021 / 04

Next Paper
DOI: 10.47183/mes.2021.039

CLINICAL CASE

Proton therapy for re-irradiation of pediatric diffuse brain stem tumors

Udalov YuD1, Slobina EL1, Danilova LA1, Zheludkova OG2, Kiselev VA1,4, Nezvetsky AV1, Demidova AM1,4, Ivanov AV1, Dykina AV3
About authors

1 Federal Research and Clinical Center for Medical Radiology and Oncology of FMBA, Dimitrovgrad, Russia

2 Voyno-Yasenetsky Research and Practical Center of Specialized Medical Care for Children, Moscow, Russia

3 Russian Scientific Center for Roentgenoradiology, Moscow, Russia

4 Dimitrovgrad Institute of Engineering and Technology of the National Research Nuclear University MEPhI, Dimitrovgrad, Russia

Correspondence should be addressed: Elena L. Slobina
Kurchatova, 5V, Dimitrovgrad, 433507, Russia; ur.liamrmcvf@anibols

About paper

Funding: the article is part of the research project on Creating and maintaining a database of patients undergoing proton therapy for cancer for FMBA, Russia and was conducted under the State Assignment 388-00141-21-00 dated December 24, 2020.

Author contribution: Udalov YuD initiated the publication; Slobina EL delivered medical care and photon irradiation at the first stage of treatment and was responsible for writing the manuscript; Danilova LA chairman of the medical council that proposed treatment strategy; Zheludkova OG pediatric oncologist, that proposed treatment strategy and supervised all stages of treatment; Kiselev VA calculated total radiation doses and their temporal and spatial distribution at all treatment stages; Nezvetsky AV delivered medical care and proton irradiation at the second stage of treatment; Demidova AM planned proton therapy; Ivanov AV responsible for the anesthetic support of the patient's radiation therapy sessions; Dykina AV planned photon therapy.

Received: 2021-10-04 Accepted: 2021-11-12 Published online: 2021-12-07
|
  1. Huhlaeva EA, Konovalov AN, Pronin IN, Kornienko VN, Gavryushin AV. Nejroradiologija i principy klassifikacii opuholej stvola golovnogo mozga. Medicinskaja vizualizacija. 2011; 6: 62–74. Russian.
  2. Shherbenko OI, Parhomenko RA, Zelinskaya NI, Antonenko FF. Luchevaja i himioluchevaja terapija diffuzno rastushhih opuholej stvola mozga u detej: vlijaet li ad"juvantnaja himioterapija na rezul'taty? Onkopediatrija. 2015; 2 (3): 188–192. DOI 10.15690/onco.v2.i3.1396. Russian.
  3. Shcherbenko OI, Parkhomenko RA, Zelinskaya NI, Antonenko FF. The role of adjuvant chemotherapy for radiation therapy of diffusely growing tumors of the brain stem in children. The Russian Journal of Pediatric Hematology аnd Oncology. 2016; 5: 95.
  4. Shcherbenko OI, Kumirova EV. K voprosu o vozmozhnostjah personalizacii primenenija himioterapii opuholej mozga na primere temozolomida. Voprosy gematologii/onkologii i immunopatologii v pediatrii. 2017; 16 (2): 84–90. DOI 10.24287/1726-1708-201716-2-84-90. Russian.
  5. Guillamo JS, Doz F, Delattre JY. Brain stem gliomas. Current opinion in neurology. 2001; 14: 711–5.
  6. Veldhuijzen van Zanten SEM, El-Khouly FE, Jansen MHA, Bakker DP, Aliaga ES, Haasbeek CJA. et al. A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol. 2017; 135 (2): 307– 315. DOI 10.1007/s11060-017-2575-9.
  7. Zalucky IV, Zhavrid EA, Mashevsky AA, Krutilina NI, Minailo II, Artemova NA, i dr. Luchevaja terapija opuholej central'noj nervnoj sistemy. Ukraїns'kij radіologіchnij zhurnal. 2007; 2 (25): 150–153.
  8. Shcherbenko OI, Parhomenko RA, Zelinskaya NI. Sovremennye vozmozhnosti konservativnogo lechenija neoperabel'nyh gliom golovnogo mozga u detej na primere diffuznorastushhih opuholej stvola mozga. Onkopediatrija. 2014; 3: 85. Russian.
  9. Slobina EL, Antonenko FF, Zelinskaya NI. Primenenie tehnologii VMAT v lechenii opuholej u detej. Issledovanija i praktika v medicine. 2017; 4 (S1): 97. Russian.
  10. Rusakova AD, Velcheva AI, Lushnikova NE. Novye metody luchevogo lechenija opuholej golovnogo mozga. Universitetskaja medicina Urala. 2021; 7 (2): 25–26. Russian.
  11. Slobina E, Abbasova E, Zheludkova O, Smyslov A, Dykina A, Vasilyev V, et al. PET-CT for Radiotherapy Planning of Pediatric Central Nervous System (CNS) Tumors. Book of Abstracts: International Conference on Clinical PET-CT and Molecular Imaging in the Era of Theranostics (IPET-2020), Vienna, Austria, 2020 24–26 Nov. Vienna, Austria: International Atomic Energy Agency; 2020. p. 131–132.
  12. Slobina EL. Osnovy frakcionirovanija dozy luchevoj terapii. Onkologicheskij zhurnal. 2008; 2 (6): 173–86. Russian.
  13. Arnone CM, Polito VA, Mastronuzzi A, Carai A, Diomedi FC, Antonucci L, et al. Oncolytic adenovirus and gene therapy with EphA2- BiTE for the treatment of pediatric high-grade gliomas. Journal for ImmunoTherapy of Cancer. 2021; 9: e001930. DOI 10.1136/jitc-2020-001930.
  14. Shcherbenko OI, Zheludkova OG, Parkhomenko RA, Zelinskaya NI, Antonenko FF. Reirradiation treatment of diffuse brain stem tumors in children. The Russian Journal of Pediatric Hematology аnd Oncology. 2016; S: 97.
  15. Janssens GO, Gandola L, Bolle S, Mandeville H, RamosAlbiac M, van Beek K, et al. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Eur J Cancer. 2017; 73: 38– 47. DOI 10.1016/j.ejca.2016.12.007.
  16. Lassaletta A, Strother D, Laperriere N, Hukin J, Vanan MI, Goddard K, et al. Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience. Pediatr Blood Cancer. 2018; 65 (6): e26988. DOI: 10.1002/pbc.26988.
  17. Klimanov VA, Samojlov AS, Udalov YuD, Gadzhinov AE, Peshkin YA. Fizika planirovanija protonnoj luchevoj terapii. Medicinskaja radiologija i radiacionnaja bezopasnost'. 2019; 64 (2): 23–32. DOI: 10.12737/article_5ca5e2677a1a06.60363700. Russian.
  18. Shherbenko OI. Uskorennye protony v lechenii opuholej CNS u detej: obzor literatury. Prakticheskaja onkologija. 2017; 18 (3): 298–306. Russian.
  19. Udalov YuD, Kryuchko DS, Slobina EL, Stepanyuchenko EM, Danilova LA, Kiselev VA, Vasileva IV, avtory; Federal'noe gosudarstvennoe bjudzhetnoe uchrezhdenie «Federal'nyj nauchno-klinicheskij centr medicinskoj radiologii i onkologii» Federal'nogo mediko-biologicheskogo agentstva (FGBU FNKCRiO FMBA Rossii), pravoobladatel'. Baza dannyh pacientov, poluchavshih protonnuju terapiju po povodu onkologicheskih zabolevanij v sisteme FMBA Rossii. Svidetel'stvo o gosudarstvennoj registracii bazy dannyh RF #2021620627. 02.04.2021. Russian.
  20. Jansen MH, Veldhuijzen van Zanten SE, Sanchez AE, Heymans MW, Warmuth-Metz M, Hargrave D, et al. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol. 2015; 17 (1): 160–6. DOI: 10.1093/neuonc/nou104.
  21. Pierre-Aurélien B, Alexandru S, Federico DR, Justyna K, Carmine M, Didier F. Diffuse intrinsic pontine glioma in children: document or treat? World Neurosurg. 2016; 93: 485.e11–485.e14.
  22. Warren KE. Diffuse intrinsic pontine glioma: poised for progress. Front Oncol. 2012; 2: 205.
  23. Sison J, Tran H, Margol A, Tiwari N, Garcia KM, Cotter J, et al. Palliative care options for a young adult patient with a diffuse intrinsic pontine glioma. Cureus. 2017; 9 (8): e1580.
  24. Vanan MI, Eisenstat DD. DIPG in children — what can we learn from the past? Front Oncol. 2015; 5: 237.
  25. Kline C, Liu SJ, Duriseti S, Banerjee A, Nicolaides Th, Raber Sh, et al. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a singleinstitution experience. J Neurooncol. 2018; 140 (3): 629–38. DOI: 10.1007/s11060-018-2991-5.
  26. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006; 7 (3): 241–8.
  27. Jalali R, Raut N, Arora B, Gupta T, Dutta D, Munshi A, et al. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys. 2010; 77 (1): 113–8. DOI: 10.1016/j.ijrobp.2009.04.031.
  28. Bouffet E, Hawkins CE, Ballourah W, Taylor MD, Bartels UK., Schoenhoff N, et al. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation. Int J Radiat Oncol Biol Phys. 2012; 83 (5): 1541–8. DOI: 10.1016/j. ijrobp.2011.10.039.
  29. Tsang DS, Murray L, Ramaswamy V, Zapotocky M, Tabori U, Bartels U, et al. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma. Neuro Oncol. 2019 Mar 18; 21 (4): 547–57. DOI: 10.1093/neuonc/noy191. PMID: 30452715; PMCID: PMC6422429.
  30. Bakst RL, Dunkel IJ, Gilheeney S, Khakoo Y, Becher O, Souweidane MM, et al. Reirradiation for recurrent medulloblastoma. Cancer. Nov 1 2011; 117 (21): 4977–82. DOI: 10.1002/cncr.26148. Epub 2011 Apr 14. PMID: 21495027.
  31. Fontanilla HP, Pinnix CC, Ketonen LM, Woo SY, Vats TS, Rytting ME, et al. Palliative reirradiation for progressive diffuse intrinsic pontine glioma. Am J Clin Oncol. Feb 2012; 35 (1): 51–57. DOI: 10.1097/ COC.0b013e318201a2b7. PMID: 21297433.
  32. Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, et al. Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. J Neurooncol. Jun 2014; 118 (2): 305–12. DOI: 10.1007/s11060014-1428-z.
  33. Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, et al. Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. Journal of Neuro-Oncology. 2018; 138 (3), 679–80. Available from: https://doi.org/10.1007/s11060-018-2893-6.
  34. Cacciotti C, Liu KX, Haas-Kogan DA, Warren KE. Reirradiation practices for children with diffuse intrinsic pontine glioma. Neurooncol Pract. 2020 Oct 6; 8 (1): 68–74. DOI: 10.1093/nop/ npaa063. PMID: 33664971; PMCID: PMC7906270.